4. 8, og for hvilke en kausal sammenhæng med nelfinavir ikke kan udelukkes.
Post-marketing experience with nelfinavir Serious and non-serious adverse reactions from post-marketing spontaneous reports (where nelfinavir was taken as the sole protease inhibitor or in combination with other antiretroviral therapy), not mentioned previously in section 4.8, for which a causal relationship to nelfinavir cannot be excluded, are summarised below.